Uncategorized
Scancell to go public after winning reverse merger bid for troubled Neuphoria
Scancell and Neuphoria have made their union official via a reverse merger that will result in a Nasdaq listing for Scancell and a resolution for Neuphoria’s shareholders after the biotech ended its social anxiety program last year.